Cancer Researchers Show CRISPR-Edited CAR T Cells Could Improve Immunotherapy
There’s already a powerful immunotherapy that “involves engineering a patient’s T cells so they recognize and attack cancer cells,” writes one of America’s top cancer hospitals. The Memorial Sloan Kettering Cancer Center notes that CAR T cell therapy h…